Biktarvy and Sleep disorder - a phase IV clinical study of FDA data

Summary:

Sleep disorder is reported as a side effect among people who take Biktarvy (bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate), especially for people who are male, 40-49 old, have been taking the drug for 1 - 6 months also take Truvada, and have Dermatitis atopic.

The phase IV clinical study analyzes which people have Sleep disorder when taking Biktarvy. It is created by eHealthMe based on reports of 19,474 people who have side effects when taking Biktarvy from the FDA, and is updated regularly.

What is Biktarvy?

Biktarvy has active ingredients of bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate. It is often used in hiv infection. eHealthMe is studying from 19,543 Biktarvy users. Check the latest studies of Biktarvy.

What is Sleep disorder?

Sleep disorder is found to be associated with 2,107 drugs and 2,938 conditions by eHealthMe. Check the latest studies of Sleep disorder.

On Jul, 04, 2026

19,474 people reported to have side effects when taking Biktarvy.
Among them, 70 people (0.36%) have Sleep disorder.

Among these 70 people:

How long have people been on Biktarvy when they have Sleep disorder? *

What is the gender of people who have Sleep disorder when taking Biktarvy? *

female: 15.38 %
male: 84.62 %

What is the age of people who have Sleep disorder when taking Biktarvy? *

What are other drugs people take besides Biktarvy? *

What are other side effects people have besides Sleep disorder? *

Pain: 26 people, 37.14%
Stress And Anxiety: 20 people, 28.57%
Emotional Distress: 18 people, 25.71%
Anhedonia (inability to experience pleasure from activities usually found enjoyable): 17 people, 24.29%
Nausea (feeling of having an urge to vomit): 15 people, 21.43%
Chronic Kidney Disease: 12 people, 17.14%
Dizziness: 10 people, 14.29%
Osteoporosis (bones weak and more likely to break): 9 people, 12.86%
Renal Impairment (severely reduced kidney function): 8 people, 11.43%
Insomnia (sleeplessness): 7 people, 10.00%

What are the existing conditions these people have? *

Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 6 people, 8.57%
Cerebral Toxoplasmosis (parasitic disease of brain caused by the protozoan toxoplasma gondii): 5 people, 7.14%
Mycobacterium Avium Complex Infection: 5 people, 7.14%
Retinal Disorder (disease of retina): 4 people, 5.71%
High Blood Pressure: 3 people, 4.29%
High Blood Cholesterol: 2 people, 2.86%
Diabetes: 2 people, 2.86%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 2 people, 2.86%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 1.43%
Asthma: 1 person, 1.43%

* Approximation only. Some reports may have incomplete information.

Do you take Biktarvy and have Sleep disorder?

- Check whether Sleep disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Biktarvy:

Biktarvy (19,543 reports)

Sleep disorder treatments and more:

Sleep disorder (167,338 reports)

How severe was Sleep disorder and when was it recovered:

Sleep disorder in Biktarvy

Expand to all the drugs that have ingredients of bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate:

Sleep disorder and drugs with ingredients of bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate (78 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Biktarvy:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sleep disorder:

Sleep disorder (2,107 drugs)

Browse all the conditions that are associated with Sleep disorder:

Sleep disorder (2,938 conditions)

Related publications that referenced our studies

Lin SC, Su YC, Huang YS, Lee CC, "Zolpidem increased cancer risk in patients with sleep disorder: A 3-year follow-up study", Journal of Medical Sciences, 2016 Mar .
Lin SC, Su YC, Huang YS, Lee CC, "Zolpidem increased cancer risk in patients with sleep disorder: A 3-year follow-up study", Journal of Medical Sciences, 2016 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate (the active ingredients of Biktarvy) and Biktarvy (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.